Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
NCT Number: NCT03533595
STRATAFIX Symmetric PDS Plus sutures will reduce the time required for fascial closure following spinal surgery. A pilot study will aide in the design of a larger randomized controlled trial to compare suture closure time of the STRATAFIX Symmetric PDS Plus sutures versus traditional Vicryl sutures.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19107, United States
Effective and secure suture is integral in spinal surgery, creating a strong barrier for tissue repair and a seal which prevents infection of the surgical site. The goal of any suture is to close the wound while minimizing risks of complications such as wound dehiscence and surgical site infection . A new type of suture, barbed suture, uses integrated barbs to secure the suture to the tissue without requiring knots for fixation. The result is a suture that evenly distributes tension along the length of the incision, while requiring less time to close . Additionally, STRATAFIX sutures offer a "Plus" antibacterial option for their knotless sutures, which further increases the safety and efficacy of this product.
Barbed suture technologies have been utilized in a variety of specialties, but neurosurgery remains unstudied in this respect. The primary aim of this study is to assess the time to closure using STRATAFIX technology. Decreased time to closure directly translates into decreased operating room time, and thus increased savings, especially for high-volume institutions. The secondary aim of this study is to determine the risk for surgical complications using STRATAFIX. Previous studies in other specialties have shown no significant difference in rate of adverse consequences when utilizing barbed sutures. To assess this aim, patients will be evaluated for wound dehiscence, SSI, deep infection, and 30-day rate of readmission for wound infection.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Barbed Suture
Time frame: Patient followed for 6 months from surgery
STRATAFIX Symmetric PDS Plus sutures will reduce the time required for fascial closure following spinal surgery. A pilot study will aide in the design of a larger randomized controlled trial to compare suture closure time of the STRATAFIX Symmetric PDS Plus sutures versus traditional Vicryl sutures.
Time frame: Patient followed for 6 months from surgery
Subject's surgical site wound will be monitored during the protocol defined time points.
Time frame: Patient followed for 6 months from surgery
Subject's surgical site will be monitored and assessed for infection during the protocol defined time points.
Time frame: Patient followed for 30 days from surgery
Subject will be monitored for 30 days post surgery for AE's and SAE's which result in readmission to the hospital.
Thomas Jefferson University
Other
Prospective Analysis of STRATAFIX Symmetric PDS Plus Suture for Fascial Closure in Spinal Surgery; Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05345249
Bone Diseases, Fusion of Spine
Ubbergen, Gelderland, Netherlands
View Trial DetailsNCT06024785
Bone Diseases, Degeneration
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT07204288
Fusion of Spine, Sacroiliac; Fusion
Overland Park, Kansas, United States
View Trial DetailsNCT06367855
Bone Diseases, Disc Degeneration
Pathum Thani, Changwat Pathum Thani, Thailand
View Trial Details